Neogen Statistics
Total Valuation
Neogen has a market cap or net worth of $2.58 billion. The enterprise value is $3.18 billion.
| Market Cap | 2.58B |
| Enterprise Value | 3.18B |
Important Dates
The last earnings date was Tuesday, October 6, 2026, after market close.
| Earnings Date | Oct 6, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Neogen has 218.31 million shares outstanding. The number of shares has increased by 0.32% in one year.
| Current Share Class | 218.31M |
| Shares Outstanding | 218.31M |
| Shares Change (YoY) | +0.32% |
| Shares Change (QoQ) | +0.18% |
| Owned by Insiders (%) | 0.42% |
| Owned by Institutions (%) | 110.38% |
| Float | 217.33M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 35.79 |
| PS Ratio | 2.92 |
| Forward PS | 2.90 |
| PB Ratio | 1.24 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 51.77 |
| P/OCF Ratio | 30.23 |
| PEG Ratio | 3.58 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.18, with an EV/FCF ratio of 63.87.
| EV / Earnings | n/a |
| EV / Sales | 3.60 |
| EV / EBITDA | 29.18 |
| EV / EBIT | n/a |
| EV / FCF | 63.87 |
Financial Position
The company has a current ratio of 3.90, with a Debt / Equity ratio of 0.37.
| Current Ratio | 3.90 |
| Quick Ratio | 2.06 |
| Debt / Equity | 0.37 |
| Debt / EBITDA | 6.73 |
| Debt / FCF | 15.55 |
| Interest Coverage | -0.13 |
Financial Efficiency
Return on equity (ROE) is -2.67% and return on invested capital (ROIC) is -0.27%.
| Return on Equity (ROE) | -2.67% |
| Return on Assets (ROA) | -0.14% |
| Return on Invested Capital (ROIC) | -0.27% |
| Return on Capital Employed (ROCE) | -0.23% |
| Weighted Average Cost of Capital (WACC) | 12.17% |
| Revenue Per Employee | $335,357 |
| Profits Per Employee | -$21,282 |
| Employee Count | 2,636 |
| Asset Turnover | 0.26 |
| Inventory Turnover | 2.74 |
Taxes
| Income Tax | -11.60M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +98.74% in the last 52 weeks. The beta is 1.79, so Neogen's price volatility has been higher than the market average.
| Beta (5Y) | 1.79 |
| 52-Week Price Change | +98.74% |
| 50-Day Moving Average | 12.16 |
| 200-Day Moving Average | 10.24 |
| Relative Strength Index (RSI) | 44.67 |
| Average Volume (20 Days) | 5,344,224 |
Short Selling Information
The latest short interest is 11.85 million, so 5.43% of the outstanding shares have been sold short.
| Short Interest | 11.85M |
| Short Previous Month | 11.17M |
| Short % of Shares Out | 5.43% |
| Short % of Float | 5.45% |
| Short Ratio (days to cover) | 2.85 |
Income Statement
In the last 12 months, Neogen had revenue of $884.00 million and -$56.10 million in losses. Loss per share was -$0.26.
| Revenue | 884.00M |
| Gross Profit | 419.00M |
| Operating Income | -7.30M |
| Pretax Income | -67.70M |
| Net Income | -56.10M |
| EBITDA | 109.00M |
| EBIT | -7.30M |
| Loss Per Share | -$0.26 |
Balance Sheet
The company has $172.00 million in cash and $774.30 million in debt, with a net cash position of -$602.30 million or -$2.76 per share.
| Cash & Cash Equivalents | 172.00M |
| Total Debt | 774.30M |
| Net Cash | -602.30M |
| Net Cash Per Share | -$2.76 |
| Equity (Book Value) | 2.09B |
| Book Value Per Share | 9.56 |
| Working Capital | 433.00M |
Cash Flow
In the last 12 months, operating cash flow was $85.30 million and capital expenditures -$35.50 million, giving a free cash flow of $49.80 million.
| Operating Cash Flow | 85.30M |
| Capital Expenditures | -35.50M |
| Depreciation & Amortization | 116.30M |
| Net Borrowing | -20.00M |
| Free Cash Flow | 49.80M |
| FCF Per Share | $0.23 |
Margins
Gross margin is 47.40%, with operating and profit margins of -0.83% and -6.35%.
| Gross Margin | 47.40% |
| Operating Margin | -0.83% |
| Pretax Margin | -7.66% |
| Profit Margin | -6.35% |
| EBITDA Margin | 12.33% |
| EBIT Margin | -0.83% |
| FCF Margin | 5.63% |
Dividends & Yields
Neogen does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.32% |
| Shareholder Yield | -0.32% |
| Earnings Yield | -2.18% |
| FCF Yield | 1.93% |
Analyst Forecast
The average price target for Neogen is $14.00, which is 18.39% higher than the current price. The consensus rating is "Buy".
| Price Target | $14.00 |
| Price Target Difference | 18.39% |
| Analyst Consensus | Buy |
| Analyst Count | 4 |
| Revenue Growth Forecast (3Y) | 2.22% |
| EPS Growth Forecast (3Y) | 17.57% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 7, 2021. It was a forward split with a ratio of 2:1.
| Last Split Date | Jun 7, 2021 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
Neogen has an Altman Z-Score of 1.1 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.1 |
| Piotroski F-Score | 6 |